Quest Diagnostics (DGX) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 Guidance
Go back to Quest Diagnostics (DGX) Tops Q4 EPS by 6c, Beats on Revenue; Offers FY26 Guidance| Quest Diagnostics (NYSE: DGX) | Delayed: 234.40 -1.64 (0.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.04 | 52 Week High | $86.85 | |||
| Open | $235.82 | 52 Week Low | $59.66 | |||
| Day High | $237.70 | P/E | 44.14 | |||
| Day Low | $233.69 | EPS | $5.31 | |||
| Volume | 541,803 | |||||

